GSD NovaPrime® TSP SARS-CoV-2 (COVID 19) 1x96
The GSD NovaPrime® TSP SARS-CoV-2 (COVID-19) is intended for the qualitative determination of SARS-CoV-2 genomic RNA in several respiratory sample types to aid in the diagnosis of COVID-19. This product represents an improvement in comparison to its former version GSD NovaPrime® SARS-CoV-2, with less sample volume required.
The GSD NovaPrime® TSP SARS-CoV-2 RT-PCR is intended for the qualitative determination of SARS-CoV-2 genomic RNA extracted from human upper respiratory (nasal wash/swab, nasopharyngeal swab, oropharyngeal swab) specimen types collected from individuals suspected of respiratory viral infection. The analytic sensitivity shows a limit of detection of 3 copies/reaction.
This product represents an improvement in comparison to its former version GSD NovaPrime® SARS-CoV-2.
Key Benefits
- • Specimen types:nasopharyngeal wash/swab, nasal wash/swab, and oropharyngeal swab
- • Less sample volume required
- • Extraction/inhibition and positive control included
- • Approximately 1 hour turnaround time
- • Excellent performance with higher sensitivity
- • CE-IVD marked
| SKU | PCOV6111 |
|---|---|
| No. of tests | 96 |
| Time to Result | Approximately 1 hour |
| PCR cycler platforms | ABI Prism® 7500 SDS (Applied BiosystemsTM), ABI Prism® 7500 Fast SDS (Applied BiosystemsTM) , AriaMx™ (Agilent Technologies), AriaDx™ (Agilent Technologies), CFX96 Touch™ (Bio-Rad), LightCycler® 480 II (Roche), QuantStudio™ 5 (Applied BiosystemsTM) |
| Kit components | Polymerase, reverse transcriptase with RNase inhibitor, Primer-Probe-Mix, Extraction Control, Positive Control, Nuclease Free Water |
Test Instructions
-
PCOV611x_rev01_20211129 Size: (446.83 KB)